New
HealthMore in Health→
How the First PROTAC Approval for Breast Cancer Validates Induced-Proximity Drugs
Key Takeaways
- The first approved PROTAC for breast cancer validates induced proximity as a therapeutic mechanism.
- Induced-proximity medicines can degrade or modify disease-related proteins beyond traditional inhibition.
- The approval opens the door for broader drug design among previously undruggable targets.
DE
DT Editorial Team··via nature.com